Omron Corp. (OTCMKTS:OMRNY) Sees Significant Decrease in Short Interest

Omron Corp. (OTCMKTS:OMRNY) was the recipient of a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 8,701 shares, a drop of 41.5% from the December 15th total of 14,864 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 60,600 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 60,600 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

Omron Trading Down 0.1%

Shares of OMRNY traded down $0.03 during mid-day trading on Friday, reaching $25.46. The company’s stock had a trading volume of 23,498 shares, compared to its average volume of 29,949. The company has a current ratio of 2.14, a quick ratio of 1.40 and a debt-to-equity ratio of 0.13. Omron has a 52 week low of $23.23 and a 52 week high of $34.72. The company’s fifty day moving average price is $25.35 and its two-hundred day moving average price is $26.41. The stock has a market cap of $5.25 billion, a PE ratio of 26.25, a P/E/G ratio of 0.40 and a beta of 0.97.

Omron (OTCMKTS:OMRNY) last announced its quarterly earnings results on Friday, November 7th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.19). Omron had a return on equity of 3.01% and a net margin of 3.47%.The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.34 billion. On average, analysts predict that Omron will post 0.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC boosted its stake in Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,129 shares of the company’s stock after buying an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered shares of Omron from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Omron presently has a consensus rating of “Sell”.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.